Opioid glycopeptide analgesics derived from endogenous enkephalins and endorphins

Yingxue Li, Mark R. Lefever, Dhanasekaran Muthu, Jean M. Bidlack, Edward J. Bilsky, Robin Polt

Research output: Contribution to journalReview article

22 Scopus citations

Abstract

Over the past two decades, potent and selective analgesics have been developed from endogenous opioid peptides. Glycosylation provides an important means of modulating interaction with biological membranes, which greatly affects the pharmacodynamics and pharmacokinetics of the resulting glycopeptide analogues. Furthermore, manipulation of the membrane affinity allows penetration of cellular barriers that block efficient drug distribution, including the blood-brain barrier. Extremely potent and selective opiate agonists have been developed from endogenous peptides, some of which show great promise as drug candidates.

Original languageEnglish (US)
Pages (from-to)205-226
Number of pages22
JournalFuture Medicinal Chemistry
Volume4
Issue number2
DOIs
StatePublished - Feb 1 2012

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology
  • Drug Discovery

Fingerprint Dive into the research topics of 'Opioid glycopeptide analgesics derived from endogenous enkephalins and endorphins'. Together they form a unique fingerprint.

  • Cite this